Rilpivirine hydrochloride

Overview

Rilpivirine (R278474) hydrochloride is a potent and specific diarylpyrimidine (DAPY) non-nucleoside reverse transcriptase inhibitor ( NNRTI ). Rilpivirine hydrochloride has high antiviral activity against wild-type HIV ( EC 50 =0.4 nM) and mutant viruses ( EC 50 =0.1-2.0 nM). Rilpivirine hydrochloride has a high genetic barrier to resistance development of HIV .

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Viral Infection | Products > Disease Areas > Pain | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Respiratory Disease | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > MMP

Product Information

• Catalog No.: HY-10574A
• CAS No.: 700361-47-3
• Molecular Formula: C22H19ClN6
• Molecular Weight: 402.88
• Purity: 99.54%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 5 mg/mL (12.41 mM); Clear solution
• Availability: In-stock

Source

Original product source